Inhibitory effect of chitooligosaccharides on matrix metalloproteinase-9 in human fibrosarcoma cells (HT1080)

Mar Biotechnol (NY). 2006 Nov-Dec;8(6):593-9. doi: 10.1007/s10126-006-6031-7. Epub 2006 Nov 8.

Abstract

Matrix metalloproteinase-9 (MMP-9) has gelatinase activity and plays an important role in cancer invasion and metastasis. Therefore, inhibition of specific types of MMPs including MMP-9 has become an attractive target for therapeutic intervention. The aim of this study was to investigate the effect of chitooligosaccharides (COS) on activity and expression of MMP-9 in HT1080 cells. The inhibitory effect of COS with different molecular masses was examined by gelatin zymography, reverse transcriptase-polymerase chain reaction (RT-PCR), gene reporter assay, and Western blot analysis. MMP-9 inhibition in the presence of COS was clearly observed in gelatin zymography. Specifically, 1- to 3-kDa COS (COS-I) exhibited the highest inhibitory effect on MMP-9 activity in HT1080 cells among tested molecular mass fractions. It was also found that COS-I was capable of inhibiting both gene and protein expression of MMP-9 (P<0.01). These results suggest that low molecular mass COS can be considered as a potent inhibitor of MMP-9.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Chitin / chemistry
  • Chitin / metabolism
  • Chitin / pharmacology*
  • Fibrosarcoma / enzymology*
  • Gene Expression Regulation, Enzymologic
  • Humans
  • Matrix Metalloproteinase 9 / genetics
  • Matrix Metalloproteinase 9 / metabolism
  • Matrix Metalloproteinase Inhibitors*
  • Oligosaccharides / chemistry
  • Oligosaccharides / metabolism
  • Oligosaccharides / pharmacology*
  • Transcription, Genetic

Substances

  • Matrix Metalloproteinase Inhibitors
  • Oligosaccharides
  • Chitin
  • Matrix Metalloproteinase 9